Latest information on COVID-19
Support teaching, research, and patient care.
Dr. McConnell is an MIT-trained bioengineer who completed his MD at Stanford followed by cardiology fellowship and cardiovascular imaging training at Brigham & Women's and Beth Israel Hospitals in Boston. He joined the Stanford faculty in 1998 and remains a Clinical Professor while working nearby at Google Health. He continues part-time clinical activities at Stanford in imaging and Preventive Cardiology and teaching with Stanford Biodesign. He previously directed the Cardiovascular MRI Program and the Preventive Cardiology Clinic in the Stanford Division of Cardiovascular Medicine. His research expertise includes novel MRI and molecular imaging techniques, from mouse to man, to evaluate coronary artery and vascular diseases, including the detection and characterization of atherosclerotic plaque and vascular inflammation. He directed the NIH-funded Multi-Disciplinary Training Program in Cardiovascular Imaging at Stanford (CVIS). He was also the Director of Cardiovascular Health Innovation and led efforts to integrate mobile health technologies to improve the care of patients with or at risk for cardiovascular disease, including PI of the MyHeart Counts mHealth research study.
My overarching interest is the detection and prevention of cardiovascular disease.<br/><br/>I have spent the majority of my research career with a focus on imaging cardiovascular disease for early detection and to guide therapy. I have been particularly interested in studying coronary and vascular diseases, including atherosclerosis and aortic aneurysms. Projects include MRI for both noninvasive coronary angiography and cellular/structural characterization of atherosclerotic plaque and aortic aneurysms, as well as other molecular imaging techniques (bioluminescence, fluorescence, and PET) for the assessment of vascular inflammation in pre-clinical models and patients. Additional collaborative projects included coronary CTA and cardiac MRI of ischemic heart disease and stem cell therapy.<br/><br/>My prevention research has expanded beyond early detection to study innovative mobile health technologies in patients and populations. I led the effort of Stanford Cardiovascular Health to leverage mHealth to improve cardiovascular care, through patient studies to enhance heart-healthy activities, sensor development, remote monitoring/detection, and collaboration with the Stanford Biomedical Data Sciences Initiative, Center for Longevity, and Prevention Research Center. I led the development of the MyHeart Counts mHealth research study launched as part of Apple's ResearchKit.<br/><br/>I have continued to pursue novel technologies for the prevention and care of cardiovascular disease as Head of Cardiovascular Health Innovations at Verily Life Sciences, and now at Google Health, while continuing part-time clinical and teaching activities at Stanford.